Plinabulin-Associated Neutrophil Demargination: Evidence for a Clinically Relevant Mechanism of Action for the Prevention of Chemotherapy-Induced-Neutropenia
Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy-Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients
Plinabulin (Plin), a Small Molecule with Anti-Cancer Activity and a Novel Mechanism of Action (MoA) in Docetaxel (Tax) Induced Neutropenia: Phase (φ) 2 Results from a Head-to-Head Comparison with Pegfilgrastim (Peg)
Plinabulin Ameliorates Chemotherapy-Induced Neutropenia: Mechanistic Insights
Guanine Nucleotide Exchange Factor-H1 Signaling is Critical for Induction of Anti-Tumor Immunity Induced by Microtubule-Depolymerizing Drugs
© 2020 BeyondSpring Inc. All rights reserved.